Ten years of work by researchers from the University of Melbourne's, Bio21 Molecular Science and Biotechnology Institute and the Florey Institute of Neuroscience and Mental Health, a human trial for a drug that could fight Motor Neurone Disease has begun.

Bio21's Professor Andrew Holmes has been recognised with Australia’s highest honour, Companion in the General Division of the Order of Australia in the 2017 Australia Day Honours list.

Bio21's Professor Paul Mulvaney is the new Director of the Centre of Excellence in Exciton Science.

Professor O’Hair, from the University’s School of Chemistry and Bio21 Institute's study has been published in Nature Communications today.

Paul Mulvaney, University of Melbourne

The Bio21 Institute would like to congratulate Professor Andrew Holmes, who has just been appointed a Fellow of the US National Academy of Inventors.